Vaccine Chaos Is Looming
The COVID-19 vaccines furthest along in clinical trials are the fastest to make, but they are also the hardest to deploy.
Related Articles
The Gut-Brain Axis Takes Center Stage
A rapid expansion of new discoveries and knowledge lays the foundation for a new era in medicine
The Drivers of Age-Related Diseases
New insights on the pivotal role of Immunosenescence and Inflammaging
Study Suggests Weight-Loss Pill is as Effective as Ozempic (Gift Article)
The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.
People With Severe Diabetes Are Cured in Small Trial of New Drug (Gift Article)
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more…
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
In people with overweight or obesity, once-weekly subcutaneous amycretin up to 60 mg had a safety and tolerability profile consistent with GLP-1 and amylin agonists.…
Sitting–rising test scores predict natural and cardiovascular causes of deaths in middle-aged and older men and women
AbstractAims. In a previous study, the ability to sit and rise from the floor was associated with all-cause mortality. Now, we aim to assess whether…
New approach enables body to engineer its own cells to fight cancer or autoimmunity
Injections of mRNA may offer a simpler, cheaper way to build powerful CAR-T cells
Neuroinflammation across neurological diseases
The brain’s response to injury includes the activation of intrinsic microglia and the influx of leukocytes, collectively constituting neuroinflammation, the “flame” of the brain. Although…
Michelle Monje: co-pioneer of cancer neuroscience
Michelle Monje is the Milan Gambhir Professor of Pediatric Neuro-Oncology at Stanford University, CA, USA, and a Howard Hughes Medical Institute Investigator. In March, 2025,…